Altar
Altar develops and operates proprietary technologies to commercialize microbes. Altar's customers use microorganisms to make food, fragrances, cosmetics, fuels, chemicals, and health products. Learn more
Financials
Estimates*
| EUR | 2019 | 2020 | 2021 |
|---|---|---|---|
| Revenues | <1m | <1m | <1m |
| % growth | - | (48 %) | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
€50.0k | Grant | ||
€2.0m | Grant | ||
N/A | Early VC | ||
* | N/A | Acquisition | |
| Total Funding | €2.1m | ||
Related Content
Recent News about Altar
EditMore about Altar
EditDeveloper of automated cultivation devices designed to harness natural selection to make better microbes. The company's devices are fully automated and ensure 24/7 permanent proliferation of cell suspensions without contamination for indefinite periods of time through counter-selection of biofilms, enabling industries to improve microorganism performance via natural selection.
Keywords: Pharmaceuticals and Biotechnology, White Biotechnology, Industrial Biotechnology, Industrial Microbial Hosts, Sustainable Industry And Goods, In Vivo Directed Evolution, Adaptive Laboratory Evolution, Natural Selection, Digitalization.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.